The Turkish Journal of Pediatrics 2019 , Vol 61 , Num 6
Vedolizumab treatment in a patient with X-linked agammaglobulinemia, is it safe and efficient?
Şükrü Çekiç 1 ,Taner Özgür 2 ,Yasin Karalı 1 ,Tanju Özkan 2 ,Sara Şebnem Kılıç 1
1 Divisions of Pediatric Immunology, Uludağ University Faculty of Medicine, Bursa, Turkey
2 Pediatric Gastroenterology, Department of Pediatrics, Uludağ University Faculty of Medicine, Bursa, Turkey
DOI : 10.24953/turkjped.2019.06.016 Keywords :
Copyright © 2016 turkishjournalpediatrics.org